Owen Mumford debuts UnifineOTC pen needles

Owen Mumford is launching UnifineOTC, a new line of over-the-counter pen needles designed to help pharmacies better serve patients managing diabetes amid increasing out-of-pocket healthcare costs. With a low MSRP and trusted Unifine quality, this offering creates a valuable opportunity for pharmacy teams to simplify operations while supporting patients facing coverage challenges, Owen Mumford said.

UnifineOTC eliminates the complexities of insurance billing, offering a reliable solution for patients with high copayments, high deductibles or who are uninsured or underinsured, the company claimed. By removing coverage-related barriers, pharmacies can support patients more efficiently and ensure access to high-quality diabetes care products.

[Read more: Owen Mumford expands Unistik Touch portfolio]

"As the cost of insulin has decreased, the price of the needles required to administer these medications has only risen. Ironically, some insured patients are now paying more for the needles than for the insulin itself. This simply doesn’t add up,” according to Casey Pflieger, senior director of pharmacy services. “UnifineOTC offers an affordable and accessible cash alternative for patients, while also ensuring pharmacies remain financially viable.”

Available in both 4mm x 32G and 5mm x 31G sizes, UnifineOTC is offered in 100-count and 50-count configurations to meet a variety of dispensing and budget needs. The pen needles maintain the same level of quality and performance healthcare professionals expect from the Unifine brand—now available in a straightforward, cash-only format that fits seamlessly into pharmacy workflows, Owen Mumford said.